Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
Research ArticlePractice

Challenges to diagnosing colorectal cancer during pregnancy

Mohammad Yaghoobi, Gideon Koren and Irena Nulman
Canadian Family Physician September 2009, 55 (9) 881-885;
Mohammad Yaghoobi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gideon Koren
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irena Nulman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

ABSTRACT

QUESTION My patient is 13 weeks pregnant and has experienced rectal bleeding and vomiting. Should I send her for a colonoscopy to rule out colorectal malignancies or should I wait until after delivery?

ANSWER The data on colorectal cancer in pregnancy are scarce; however, as the presenting features of colorectal cancer overlap with those of pregnancy itself, there is a risk of development of advanced disease, with poorer prognosis at diagnosis. Therefore, it is strongly recommended that this patient, who is in her second trimester, undergo at least a flexible sigmoidoscopy, which is presumed safe during pregnancy, with or without a liver ultrasound and carcinoembryonic antigen detection based on pretest probability according to her other risk factors.

Oftentimes the presenting symptoms of serious conditions overlap with common symptoms of pregnancy, such as nausea and vomiting, pruritus, or hemorrhoids. It is important not to miss critical diagnoses that might put both mother and unborn child at serious health risk. In this Motherisk Update, we focus on colorectal cancer. The risk of this condition occurring during pregnancy has increased, as more women are postponing pregnancy until later in life.

Epidemiology

Cruveilhier reported the first case of rectal carcinoma in pregnancy in 1842.1 Cancer incidence has been estimated at approximately 1 in every 1000 pregnancies.2 Colorectal cancer is the seventh most common type of cancer diagnosed in pregnancy, with an estimated incidence of 1 in 13 000 pregnancies in 1992.3 This would translate to 30 new cases a year in Canada. To our knowledge there are no more recent epidemiologic data on the incidence of colorectal cancer in pregnancy. The mean age of diagnosis in 1 large review was 31 years.4

Diagnosis of cancer during pregnancy can be a potentially devastating situation associated with serious emotional and physical stress for the pregnant woman and her family.5 The decision about abortion as a therapeutic choice could increase this burden even further. Early diagnosis and treatment are important in colorectal cancer during pregnancy.

Clinical features

Common presenting symptoms of colorectal cancer include abdominal pain, constipation, vomiting, anemia, and rectal bleeding; most of these symptoms might be attributed to pregnancy itself and be overlooked.6 Rectal bleeding can also be attributed to hemorrhoids, which are common in pregnant women. For this reason most cases of colorectal cancer are diagnosed later in pregnancy when more widespread metastasis has occurred.3

Contrary to the general population, 86% of colorectal tumours found during pregnancy occur below the peritoneal reflection.4 These tumours are detectable by flexible sigmoidoscopy without the need for sedation and radiation exposure. Cases of familial adenomatous polyposis have also been reported to be first diagnosed during pregnancies.7

Diagnosis

The American Society of Gastrointestinal Endoscopy guidelines indicate that in situations in which therapeutic intervention is necessary, endoscopy offers a relatively safe alternative to radiologic or surgical intervention.8 Endoscopy during pregnancy should be done only when there is a strong indication and should be postponed to the second trimester whenever possible. Maternal oversedation, with resulting hypoventilation or hypotension, or maternal positioning that might lead to the compression of the inferior vena cava by the uterus can potentially lead to decreased uterine blood flow and fetal hypoxia. Other potential risks to the fetus include teratogenesis (from sedative medication) and premature birth.8

Once diagnosed, the evaluation of pregnant patients with colorectal carcinoma is similar to the evaluation of nonpregnant patients.9 Examination requires the following: complete colonoscopy to screen for synchronous lesions; an endoluminal ultrasonograph to confirm staging of rectal lesions; monitoring of serum carcinoembryonic antigen levels for follow-up purposes; and a liver ultrasound for detection of metastatic liver disease. Magnetic resonance imaging is an appropriate substitute for computed tomography in staging when needed.10 When advanced rectal cancer is diagnosed in the latter stages of pregnancy, careful assessment of the tumour site and cancer stage is made to ensure that the tumour will not obstruct a normal labour and vaginal delivery.11

Fetal risk

There are no reports of adverse fetal outcomes due to the malignancy itself, even in widespread metastatic disease.12 Metastasis to the placenta was reported once in maternal colorectal malignancy.13 Although a complete evaluation of the placenta is recommended, there is no evidence to support periodic follow-up of the baby. There is a 78% rate of fetal survival in pregnancies complicated by colorectal carcinoma.6,14

Maternal colorectal malignancy might affect pregnancy outcome. Only 25 of 32 pregnancies complicated by colonic tumours resulted in healthy live-born infants in 1 study.3 Deaths were due to stillbirth, prematurity, or termination.

In the case of this patient, the fetus was not involved and was normal; therefore, there was no fetal indication for a therapeutic abortion.

Treatment

When diagnosis of colorectal cancer is made during pregnancy, multidisciplinary involvement of the obstetrician, perinatologist, colorectal surgeon, and radiation and medical oncologists is essential to achieving the goal of early delivery that allows for the earliest treatment of the patient’s cancer.14

Treatment and prognosis by cancer stage are not different from those in the general population. There are several factors to consider when planning management: location of the cancer, gestational age, elective versus emergency presentation, the stage of the tumour, complications of tumour or pregnancy, and the patient’s decision.9 Unfortunately, colon cancer in pregnancy is often diagnosed at an advanced stage when surgical management and adjuvant chemotherapy are barely effective. Figures 1 and 2 are the proposed guidelines by Walsh and Fazio.9

Figure 1
  • Download figure
  • Open in new tab
Figure 1

Management of colon cancer in pregnancy

Figure 2
  • Download figure
  • Open in new tab
Figure 2

Management of rectal cancer in pregnancy

Surgery could be performed safely before 20 weeks of gestation when appropriate.15 After this gestational age it is recommended that surgery be delayed to have a reasonable maturation of the fetus. It has been proposed that colon cancer surgery can be done right after an uncomplicated cesarean section.9 Intraoperatively, the patient should be placed in the slight left lateral position to prevent uterine compression of the inferior vena cava and left iliac vein. Maternal blood gases should be monitored, as carbon dioxide insufflation can induce maternal hypercapnia, which can lead to fetal hypercapnia, tachycardia, and hypertension.16

The mode of delivery is not affected by cancer, with the exception of a cesarean section owing to a distal tumour obstructing the birth canal or anterior rectal wall carcinoma. The placenta should be carefully examined for metastases.17

Adjuvant chemotherapy with 5-fluorouracil (5-FU) is suggested for stage III tumours; however, the risk and benefits should be discussed with the patient.9 The most serious complications occur when the chemotherapy is given from 3 to 12 weeks of gestation.18 In animal models, this agent is highly teratogenic. In several case reports, 5-FU during the first trimester has been associated with spontaneous abortion as well as normal-term births.19–23 In one case, a patient who had 5-FU administered in high doses over 5 months of the second and third trimesters gave birth to a healthy but small baby.24 Moreover, no congenital anomalies or other clinically significant adverse effects were observed in 40 infants whose mothers were treated for breast cancer during the second and third trimesters of pregnancy with intravenous fluorouracil in combination with doxorubicin, cyclophosphamide, and other chemotherapeutic agents.25–27 Transient cyanosis and jerky movements were reported in a newborn whose mother received 5-FU during the third trimester.28 There are no reports on the use of 5-FU during lactation. Cisplatin and other platinum-based chemotherapy drugs are also used in colorectal cancer, but they are not recommended during pregnancy or breastfeeding.29

Chemotherapy is safer during the second and third trimester of pregnancy, although there is an increase in the incidence of intrauterine growth retardation and prematurity.30 Although a few cancer chemotherapy studies have failed to show adverse effects in treatment in the third trimester, the possible neurocognitive effect of chemotherapy cannot be totally excluded because brain development is not completed during pregnancy or even early in life.31

Adjuvant radiotherapy is used in the management of rectal cancer. Radiation therapy to the pelvis is not recommended during pregnancy because of the potential harm to the fetus. Fetal radiation exposure should be measured by a medical physicist in any radiation during pregnancy.32 Pelvic radiation after delivery can be considered, but should be discussed with the patient, as it might end in infertility.33

Conclusion

Colorectal carcinoma is a rare but devastating event during pregnancy. Because presentation can overlap with the signs and symptoms of pregnancy, diagnoses are often a challenge. Principles of treatment of colorectal cancer during pregnancy are not different from those in the general population, but special care regarding fetal safety should be considered.

MOTHERISK

Motherisk questions are prepared by the Motherisk Team at the Hospital for Sick Children in Toronto, Ont. Dr Yaghoobi is a resident in the Department of Medicine at the University of Toronto in Ontario and was a member of the Motherisk Program at the time of preparing this update. Dr Nulman is Associate Director and Dr Koren is Director of the Motherisk Program. Dr Koren is supported by the Research Leadership for Better Pharmacotherapy during Pregnancy and Lactation. He holds the Ivey Chair in Molecular Toxicology in the Department of Medicine at the University of Western Ontario in London.

Do you have questions about the effects of drugs, chemicals, radiation, or infections in women who are pregnant or breastfeeding? We invite you to submit them to the Motherisk Program by fax at 416 813-7562; they will be addressed in future Motherisk Updates.

Published Motherisk Updates are available on the Canadian Family Physician website (www.cfp.ca) and also on the Motherisk website (www.motherisk.org).

Footnotes

  • Competing interests

    None declared

  • Copyright© the College of Family Physicians of Canada

References

  1. ↵
    CruveilhierJJAnatomie pathologique du corps humaine2Paris, FranceJB Baillière1829710
    OpenUrl
  2. ↵
    DoneganWLCancer and pregnancyCA Cancer J Clin1983334194214
    OpenUrlPubMed
  3. ↵
    WoodsJBMartinJNJrIngramFHOdomCDScott-ConnerCERhodesRSPregnancy complicated by carcinoma of the colon above the rectumAm J Perinatol19929210210
    OpenUrlPubMed
  4. ↵
    BernsteinMAMadoffRDCaushajPFColon and rectal cancer in pregnancyDis Colon Rectum19933621728
    OpenUrlCrossRefPubMed
  5. ↵
    OduncuFSKimmigRHeppHEmmerichBCancer in pregnancy: maternal fetal conflictJ Cancer Res Clin Oncol2003129313346Epub 2003 Mar 18
    OpenUrlPubMed
  6. ↵
    VitoratosNSalamalekisEMakrakisECreatsasGSigmoid colon cancer during pregnancyEur J Obstet Gynecol Reprod Biol20021041702
    OpenUrlCrossRefPubMed
  7. ↵
    LolisEDLikoudisPVoiniadisPHassiakosDSamanidesLSynchronous rectal and colon cancer caused by familial polyposis coli during pregnancyJ Obstet Gynaecol Res2007332199202
    OpenUrlPubMed
  8. ↵
    QureshiWARajanEAdlerDGDavilaREHirotaWKJacobsonBCASGE guideline: guidelines for endoscopy in pregnant and lactating womenGastrointest Endosc200561335762
    OpenUrlCrossRefPubMed
  9. ↵
    WalshCFazioVWCancer of the colon, rectum, and anus during pregnancy. The surgeon’s perspectiveGastroenterol Clin North Am199827125767
    OpenUrlPubMed
  10. ↵
    MoranBJYanoHAl ZahirNFarquharsonMConflicting priorities in surgical intervention for cancer in pregnancyLancet Oncol20078653644
    OpenUrlCrossRefPubMed
  11. ↵
    LamerzRRuiderHSignificance of CEA determinations in patients with cancer of the colon-rectum and the mammary gland in comparison to physiological states in connection with pregnancyBull Cancer197663457586
    OpenUrlPubMed
  12. ↵
    HeresPWiltinkJCuestaMABurgerCWvan GroeningenCJMeijerSColon carcinoma during pregnancy: a lethal coincidenceEur J Obstet Gynecol Reprod Biol199348214952
    OpenUrlPubMed
  13. ↵
    RothmanLACohenCJAstarloaJPlacental and fetal involvement by maternal malignancy: a report of rectal carcinoma and review of the literatureAm J Obstet Gynecol19731167102334
    OpenUrlPubMed
  14. ↵
    KitohTNishimuraSFukudaSHirabukiSKaganoiJTokunagaYThe incidence of colorectal cancer during pregnancy in Japan: report of two cases and review of Japanese casesAm J Perinatol199815316571
    OpenUrlPubMed
  15. ↵
    Cohen-KeremRRailtonCOrenDLishnerMKorenGPregnancy outcome following non-obstetric surgical interventionAm J Surg2005190346773
    OpenUrlCrossRefPubMed
  16. ↵
    SchirmerBKouretasPCCameronJLGallstone pancreatitisCurrent surgical therapy7th edPhiladelphia, PAMosby200152833
  17. ↵
    DildyDA3rdMoiseKJJrCarpenterRJJrKlimaTMaternal malignancy metastatic to the products of conception: a reviewObstet Gynecol Surv198944753540
    OpenUrlPubMed
  18. ↵
    PentheroudakisGPavlidisNCastiglioneMESMO Guidelines Working GroupCancer, fertility and pregnancy: ESMO clinical recommendations for diagnosis, treatment and follow-upAnn Oncol200819Suppl 2ii1089
    OpenUrlFREE Full Text
  19. ↵
    GiannakopoulouCManouraAHatzidakiEKorakakiEFroudarakisGKoumandakisEMultimodal cancer chemotherapy during the first and second trimester of pregnancy: a case reportEur J Obstet Gynecol Reprod Biol2000911957
    OpenUrlCrossRefPubMed
  20. AndreadisCCharalampidouMDiamantopoulosNChouchosNMouratidouDCombined chemotherapy and radiotherapy during conception and first two trimesters of gestation in a woman with metastatic breast cancerGynecol Oncol20049512525Erratum in: Gynecol Oncol 2005;96(1)267
    OpenUrlCrossRefPubMed
  21. ZemlickisDLishnerMDegendorferPPanzarellaTSutcliffeSBKorenGFetal outcome after in utero exposure to cancer chemotherapyArch Intern Med199215235736
    OpenUrlCrossRefPubMed
  22. KopelmanJNMiyazawaKInadvertent 5-fluorouracil treatment in early pregnancy: a report of three casesReprod Toxicol1990432335
    OpenUrlPubMed
  23. ↵
    OdomLDPlouffeLJrButlerWJ5-Fluorouracil during the period of conception: report on two casesAm J Obstet Gynecol19901631 Pt 1767
    OpenUrlPubMed
  24. ↵
    DreicerRLoveRRHigh total dose 5-fluorouracil treatment during pregnancyWis Med J199190105823
    OpenUrlPubMed
  25. ↵
    BerryDLTheriaultRLHolmesFAParisiVMBooserDJSingletarySEManagement of breast cancer during pregnancy using a standardized protocolJ Clin Oncol199917385561
    OpenUrlAbstract/FREE Full Text
  26. RingAESmithIEJonesAShannonCGalaniEEllisPAChemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitalsJ Clin Oncol2005231841927
    OpenUrlAbstract/FREE Full Text
  27. ↵
    MathelinCAnnaneKDufourPLiegeoisPBergeratJPChemotherapy for breast cancer during pregnancyEur J Obstet Gynecol Reprod Biol 200512332602Epub 2005 Jul 15
    OpenUrlCrossRefPubMed
  28. ↵
    StadlerHEKnowlesJFluorouracil in pregnancy: effect on the neonateJAMA197121722145
    OpenUrlCrossRefPubMed
  29. ↵
    BriggsGGFreemanRKYaffeSJDrugs in pregnancy and lactation5th edBaltimore, MDWilliams and Wilkins Co1998
  30. ↵
    SommersGMKaoMSUsing chemotherapeutic agents during pregnancyContemp Obstet Gynecol198730458
    OpenUrl
  31. ↵
    NulmanILasloDFriedSUlerykELishnerMKorenGNeurodevelopment of children exposed in utero to treatment of maternal malignancyBr J Cancer2001851116118
    OpenUrlCrossRefPubMed
  32. ↵
    PeregDKorenGLishnerMCancer in pregnancy: gaps, challenges and solutionsCancer Treat Rev 200834430212Epub 2008 Mar 4
    OpenUrlCrossRefPubMed
  33. ↵
    DevitaVTHellmanSRosenbergSACancer. Principles and practice of oncology3rd edPhiladelphia, PAJB Lippincott1989
PreviousNext
Back to top

In this issue

Canadian Family Physician: 55 (9)
Canadian Family Physician
Vol. 55, Issue 9
1 Sep 2009
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Challenges to diagnosing colorectal cancer during pregnancy
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Challenges to diagnosing colorectal cancer during pregnancy
Mohammad Yaghoobi, Gideon Koren, Irena Nulman
Canadian Family Physician Sep 2009, 55 (9) 881-885;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Challenges to diagnosing colorectal cancer during pregnancy
Mohammad Yaghoobi, Gideon Koren, Irena Nulman
Canadian Family Physician Sep 2009, 55 (9) 881-885;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • ABSTRACT
    • Epidemiology
    • Clinical features
    • Diagnosis
    • Fetal risk
    • Treatment
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Practice

  • Is 45 the new 50 in colorectal cancer screening?
  • Approach to diagnosis and management of childhood attention deficit hyperactivity disorder
  • Determining if and how older patients can safely stay at home with additional services
Show more Practice

Motherisk Update

  • Hepatitis A infection during pregnancy
  • Fluconazole use during breastfeeding
  • Is it safe to breastfeed while taking methylphenidate?
Show more Motherisk Update

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • RSS Feeds

Copyright © 2023 by The College of Family Physicians of Canada

Powered by HighWire